09 - Chapter 9 Cost of Capital
09 - Chapter 9 Cost of Capital
Cost of Capital
9-1
Learning Goals
LG1
LG2
LG3
9-2
LG5
LG6
9-3
9-4
9-5
9-6
9-7
Focus on Ethics
The Ethics of Profit
Introduced in 1999, Vioxx was an immediate success,
quickly reaching $2.5 billion in annual sales.
However, a Merck study launched in 1999 eventually found
that patients who took Vioxx suffered from an increased
risk of heart attacks and strokes.
Despite the risks, Merck continued to market and sell
Vioxx.
Vioxx was withdrawn from the market in 2006, dealing a
severe blow to the firms reputation, profits, and stock
price.
The Vioxx recall increased Mercks cost of capital. What effect
would an increased cost of capital have on a firms future
investments?
9-8
9-9
9-10
9-11
9-12
9-13
9-14
where
9-15
9-16
9-17
9-18
9-19
9-20
9-21
9-22
where
9-23
9-24
9-25
9-26
9-27
9-28
9-29
9-30
9-31
Matter of Fact
Retained Earnings, the Preferred Source of Financing
In the United States and most other countries,
firms rely more heavily on retained earnings than
any other source of financing.
For example, a 2013 survey of Chinese firms
found that 64% of the companies surveyed listed
retained earnings as one of their primary sources
of funds.
Bank loans were a distant second choice,
mentioned as a primary source of funds by just
44% of companies.
9-32
9-33
9-34
9-35
9-36
9-37
9-38
Cost
Cost
Cost
Cost
of
of
of
of
debt, ri = 5.6%
preferred stock, rp = 10.6%
retained earnings, rr = 13.0%
new common stock, rn = 14.0%
9-39
9-40
Focus on Practice
Uncertain Times Make for an Uncertain Weighted Average Cost of
Capital
As U.S. financial markets experienced and recovered from the
2008 financial crisis and 2009 great recession, firms struggled
to keep track of their weighted average cost of capital since the
individual component costs were moving rapidly in response to
the financial market turmoil.
The financial crisis pushed credit costs to a point where long-term
debt was largely inaccessible, and the great recession saw
Treasury bond yields fall to historic lows making cost of equity
projections appear unreasonably low.
Ron Domanico is the CFO at Caraustar Industries, Inc. and he
reported that his company dealt with the cost-of-capital
uncertainty by abandoning the one-size-fits-all approach.
Why dont firms generally use both a short and long-run weighted
average cost of capital?
9-41
9-42
9-43
9-44
9-45
9-46
9-47
9-48
9-49
9-50
9-51
9-52
9-53
9-54
9-55
9-56